Wired.com has switched its reporting narrative from targeting those who question vaccine science to now questioning the data themselves from AstraZeneca’s forthcoming Covid vaccine.

THE MAKERS OF a third coronavirus vaccine announced positive results in clinical trials on Monday, setting off yet another round of excited news reports. This one, produced by a partnership between a University of Oxford research institute, its spinout company Vaccitech, and the pharmaceutical company AstraZeneca, does not need to be stored at freezing temperatures and would be cheaper and easier to produce than the high-efficacy vaccines produced by BioNTech-Pfizer and Moderna. Indeed, according to an initial write-up in The New York Times, Oxford-AstraZeneca’s is “expected to be relied upon heavily across the globe, to help curb a pandemic that has killed more than 1.3 million people.”

Sounds like great news, right? Monday’s press release from AstraZeneca presents “convincing evidence that [the vaccine] works,” said Science. But not everyone has been convinced. The price of AstraZeneca’s shares actually dropped on the news, and an analysis from an investment bank concluded, “We believe that this product will never be licensed in the US.” Over at STAT News, Anthony Fauci cautioned that we’ll need to see more data before coming to a conclusion. The skeptics have strong reasons to be concerned: This week’s “promising” results are nothing like the others that we’ve been hearing about in November—and the claims that have been drawn from them are based on very shaky science.….

CLICK HERE TO READ THE ENTIRE ARTICLE AT WIRE.COM

Derek Kramer

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

American Children Face 80% Higher Death Risk Than Peers in Wealthy Nations, JAMA Study Finds

A new study in JAMA found that US infants under the age of 1 are 1.78 times more likely to die than OECD countries, which are high-income nations. In addition, the study authors found that children aged 1-19 are 1.8 times more likely to die than children in the other 18 countries. From 2011 toContinue reading American Children Face 80% Higher Death Risk Than Peers in Wealthy Nations, JAMA Study Finds

More news about Health & Nutrition

Vaccines

Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

Moderna received full FDA approval for its COVID-19 mRNA vaccine, called SpikeVax, for use in children aged 6 months to 11 years who are considered high risk. Previously, this vaccine was only given an Emergency Use Authorization (EUA) for this age group. In May, the CDC announced a change in its COVID-19 vaccine policy, noContinue reading Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

More news about Vaccines

Science & Tech

Coinbase CEO Brian Armstrong Eyes Embryo-Editing Startup

Coinbase CEO Brian Armstrong declared his interest in creating a startup to work on gene-editing embryos, a type of editing that people say will lead to the creation of “designer babies.” CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been used in the medical field to help with certain conditions, and recently, a babyContinue reading Coinbase CEO Brian Armstrong Eyes Embryo-Editing Startup

More news about Science & Tech

Environment

USDA to Build Sterile Fly Factory to Stop Flesh-Eating Maggots from Invading U.S.

The USDA is going to breed millions of flies, sterilize them with radiation, and send them into Texas and Mexico to prevent a re-emergence of the New World Screwworm(NWS), also known as a flesh-eating maggot. The NWS is endemic to Cuba, the Dominican Republic, and some South American countries, but it was eradicated in theContinue reading USDA to Build Sterile Fly Factory to Stop Flesh-Eating Maggots from Invading U.S.

More news about Environment

Policy

Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

Moderna received full FDA approval for its COVID-19 mRNA vaccine, called SpikeVax, for use in children aged 6 months to 11 years who are considered high risk. Previously, this vaccine was only given an Emergency Use Authorization (EUA) for this age group. In May, the CDC announced a change in its COVID-19 vaccine policy, noContinue reading Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

More news about Policy